Laddar...
Reading between the lines; understanding drug response in the post genomic era
Following the fanfare of initial, often dramatic, success with small molecule inhibitors in the treatment of defined genomic subgroups, it can be argued that the extension of targeted therapeutics to the majority of patients with solid cancers has stalled. Despite encouraging FDA approval rates, the...
Sparad:
| I publikationen: | Mol Oncol |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley and Sons Inc.
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5528621/ https://ncbi.nlm.nih.gov/pubmed/24957465 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2014.05.014 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|